KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Inventory (2016 - 2025)

NovoCure (NVCR) has disclosed Inventory for 12 consecutive years, with $41.1 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 17.17% to $41.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.1 million through Dec 2025, up 17.17% year-over-year, with the annual reading at $41.1 million for FY2025, 17.17% up from the prior year.
  • Inventory hit $41.1 million in Q4 2025 for NovoCure, up from $39.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $42.4 million in Q1 2024 to a low of $22.6 million in Q3 2021.
  • Historically, Inventory has averaged $33.7 million across 5 years, with a median of $34.1 million in 2023.
  • Biggest five-year swings in Inventory: decreased 14.49% in 2021 and later surged 37.38% in 2023.
  • Year by year, Inventory stood at $24.4 million in 2021, then rose by 20.26% to $29.4 million in 2022, then rose by 29.87% to $38.2 million in 2023, then fell by 8.04% to $35.1 million in 2024, then rose by 17.17% to $41.1 million in 2025.
  • Business Quant data shows Inventory for NVCR at $41.1 million in Q4 2025, $39.1 million in Q3 2025, and $40.2 million in Q2 2025.